-
Judaism is practiced in many diverse ways in the United States, yet sometimes even non-practicing Jews still observe Jewish laws at the end of life, suggests Barry Kinzbrunner, MD, chief medical officer for VITAS Innovative Hospice Care in Miami.
-
-
-
You have just taken sign-out when a nurse comes up to you and says that there is a 64-year-old man in the critical bay who took an overdose of his medications. The patient has a history of hypertension, atrial fibrillation, and depression. The patient is lethargic but arousable, and reports he took about 40 tablets of immediate-release metoprolol three hours ago in an attempt to "end it all." The nurses are starting IV lines, checking vitals, and putting the patient on the monitor. You wonder, "Is it too late for gastric decontamination? If he is symptomatic, which therapy will I try first, and what are my options?"
-
Young minority men who have sex with men (MSM) are most at risk of HIV infection in the United States, so there needs to be more prevention options and strategies addressing their vulnerability. Microbicides may be an answer.
-
A national study has found that antiretroviral therapy (ART) drugs are underused among people who seek HIV care from HIV clinics at seven sites across the United States.
-
The Centers for Disease Control and Prevention is issuing $11.6 million in grants to support demonstration projects that implement a combination approach to HIV prevention inclusive of treatment, care, and social services in 12 hard-hit areas across the country.
-
The Food and Drug Administration (FDA) approved changes to the labeling for entecavir (Baraclude®) to provide a dosing regimen for adult patients with chronic hepatitis B (HBV) and decompensated liver disease, based on efficacy data through Week 48 and cumulative safety data from one trial.
-
After a rocky decade, the microbicides field finally is seeing some success, opening up a promising future that should include a wider range of HIV prevention options for women as well as for men who have sex with men (MSM).
-
The HIV community has waited a long time but there might finally be some rewards when the first microbicide options become available worldwide. Among these options are an intravaginal ring that delivers dapivirine and the daily use of tenofovir vaginal gel.
